Gene therapy holds great promise, particularly for rare disease with a genetic basis. However, the field is in it early stages, and the ideal methods and solutions for unlocking the full potential of gene therapy are still being developed.

This free white paper from Eugene Koren, Senior Scientific Advisor for Immunology, Karen Richards, Senior VP of IVD, and Elizabeth Ludington, Senior Vice President of Biometrics will help you:

• Understand current FDA guidance and regulations for gene therapy
• Learn key considerations when initiating gene therapy trials
• Plan for the concurrent development of a companion diagnostic including development of an AAV NAb assay